{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:43:38Z","timestamp":1790642618453,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005781","name":"Koneen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"DOI":"10.1186\/s12954-025-01330-9","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T10:06:12Z","timestamp":1761905172000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["From trash to results: shortcomings and benefits of paraphernalia-based drug checking in Finland"],"prefix":"10.1186","volume":"22","author":[{"given":"Teemu","family":"Kaskela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne","family":"Nahkuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aino","family":"Kankaanp\u00e4\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pelander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teemu","family":"Gunnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Tuomas","family":"Harviainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jouni","family":"Tourunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"1330_CR1","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1108\/DHS-01-2022-0007","volume":"23","author":"MJ Barratt","year":"2022","unstructured":"Barratt MJ, Measham F. What is drug checking anyway? DHS. 2022;23:176\u201387.","journal-title":"DHS"},{"key":"1330_CR2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/09687637.2022.2072187","volume":"30","author":"H Valente","year":"2023","unstructured":"Valente H, Martins D, Pinto M, Fernandes L, Barratt MJ. A longitudinal study of behavioural outcomes following a visit to the boom festival 2018 drug checking service: individual and group level results. Drugs Educ Prev Policy. 2023;30:373\u201382.","journal-title":"Drugs Educ Prev Policy"},{"key":"1330_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103270","volume":"95","author":"F Measham","year":"2021","unstructured":"Measham F, Turnbull G. Intentions, actions and outcomes: a follow up survey on harm reduction practices after using an English festival drug checking service. Int J Drug Policy. 2021;95:103270.","journal-title":"Int J Drug Policy"},{"key":"1330_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-023-00764-3","volume":"20","author":"L Gozdzialski","year":"2023","unstructured":"Gozdzialski L, Wallace B, Hore D. Point-of-care community drug checking technologies: an insider look at the scientific principles and practical considerations. Harm Reduct J. 2023;20:39.","journal-title":"Harm Reduct J"},{"key":"1330_CR5","volume-title":"Global review of drug checking services operating in 2017","author":"MJ Barratt","year":"2018","unstructured":"Barratt MJ, Kowalski M, Maier LJ, Ritter A. Global review of drug checking services operating in 2017. Australia: National Drug and Alcohol Research Centre, UNSW Sydney; 2018."},{"key":"1330_CR6","unstructured":"Brunt T. Drug checking as a harm reduction tool for recreational drug users: oppurtunities and challenges. European Monitoring Centre for Drugs and Drug Addiction; 2017. pp. 1\u201321."},{"key":"1330_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103409","volume":"97","author":"L Gozdzialski","year":"2021","unstructured":"Gozdzialski L, Aasen J, Larnder A, Ramsay M, Borden SA, Saatchi A, et al. Portable gas chromatography\u2013mass spectrometry in drug checking: detection of carfentanil and etizolam in expected opioid samples. Int J Drug Policy. 2021;97:103409.","journal-title":"Int J Drug Policy"},{"key":"1330_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12954-018-0208-z","volume":"15","author":"M Sande","year":"2018","unstructured":"Sande M, \u0160abi\u0107 S. The importance of drug checking outside the context of nightlife in Slovenia. Harm Reduct J. 2018;15:2\u20139.","journal-title":"Harm Reduct J"},{"key":"1330_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-021-00545-w","volume":"18","author":"A Larnder","year":"2021","unstructured":"Larnder A, Burek P, Wallace B, Hore DK. Third party drug checking: accessing harm reduction services on the behalf of others. Harm Reduct J. 2021;18:99.","journal-title":"Harm Reduct J"},{"key":"1330_CR10","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.drugpo.2018.11.001","volume":"67","author":"FC Measham","year":"2019","unstructured":"Measham FC. Drug safety testing, disposals and dealing in an english field: exploring the operational and behavioural outcomes of the uk\u2019s first onsite \u2018drug checking\u2019 service. Int J Drug Policy. 2019;67:102\u20137.","journal-title":"Int J Drug Policy"},{"key":"1330_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.drugpo.2019.07.007","volume":"73","author":"H Valente","year":"2019","unstructured":"Valente H, Martins D, Carvalho H, Pires CV, Carvalho MC, Pinto M, et al. Evaluation of a drug checking service at a large scale electronic music festival in Portugal. Int J Drug Policy. 2019;73:88\u201395.","journal-title":"Int J Drug Policy"},{"key":"1330_CR12","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/add.15734","volume":"117","author":"N Maghsoudi","year":"2022","unstructured":"Maghsoudi N, Tanguay J, Scarfone K, Rammohan I, Ziegler C, Werb D, et al. Drug checking services for people who use drugs: a systematic review. Addiction. 2022;117:532\u201344.","journal-title":"Addiction"},{"key":"1330_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-018-0252-8","volume":"15","author":"M Karamouzian","year":"2018","unstructured":"Karamouzian M, Dohoo C, Forsting S, McNeil R, Kerr T, Lysyshyn M. Evaluation of a Fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada. Harm Reduct J. 2018;15:46.","journal-title":"Harm Reduct J"},{"key":"1330_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-022-00590-z","volume":"19","author":"JJ Carroll","year":"2022","unstructured":"Carroll JJ, Mackin S, Schmidt C, McKenzie M, Green TC. The bronze age of drug checking: barriers and facilitators to implementing advanced drug checking amidst police violence and COVID-19. Harm Reduct J. 2022;19:9.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1330_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-021-11243-4","volume":"21","author":"B Wallace","year":"2021","unstructured":"Wallace B, Van Roode T, Pagan F, Hore D, Pauly B. The potential impacts of community drug checking within the overdose crisis: qualitative study exploring the perspective of prospective service users. BMC Public Health. 2021;21(1):1156.","journal-title":"BMC Public Health"},{"key":"1330_CR16","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/bcp.14231","volume":"86","author":"F Measham","year":"2020","unstructured":"Measham F. City checking: piloting the uk\u2019s first community-based drug safety testing (drug checking) service in 2 City centres. Br J Clin Pharmacol. 2020;86:420\u20138.","journal-title":"Br J Clin Pharmacol"},{"key":"1330_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-023-00830-w","volume":"20","author":"H Carver","year":"2023","unstructured":"Carver H, Falzon D, Masterton W, Wallace B, Aston EV, Measham F, et al. It\u2019s not going to be a one size fits all: a qualitative exploration of the potential utility of three drug checking service models in Scotland. Harm Reduct J. 2023;20:94.","journal-title":"Harm Reduct J"},{"key":"1330_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-023-00882-y","volume":"20","author":"C Grace Rose","year":"2023","unstructured":"Grace Rose C, Pickard AS, Kulbokas V, Hoferka S, Friedman K, Epstein J, et al. A qualitative assessment of key considerations for drug checking service implementation. Harm Reduct J. 2023;20:151.","journal-title":"Harm Reduct J"},{"key":"1330_CR19","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1108\/DHS-03-2022-0016","volume":"23","author":"F Hutton","year":"2022","unstructured":"Hutton F. Drug checking in New Zealand: the 2020 and 2021 drug and substance checking legislation acts. DHS. 2022;23:200\u20136.","journal-title":"DHS"},{"key":"1330_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109425","volume":"234","author":"CS Davis","year":"2022","unstructured":"Davis CS, Lieberman AJ, O\u2019Kelley-Bangsberg M. Legality of drug checking equipment in the United States: a systematic legal analysis. Drug Alcohol Depend. 2022;234:109425.","journal-title":"Drug Alcohol Depend"},{"key":"1330_CR21","unstructured":"Karjalainen K. Suomalaisten huumeiden k\u00e4ytt\u00f6 ja huumeasenteet \u2013 Huumeaiheiset v\u00e4est\u00f6kyselyt Suomessa 1992\u20132022 [Drug use and drug attitudes among Finns \u2013 Drug-related population surveys in Finland 1992\u20132022]. Terveyden ja hyvinvoinnin laitos; 2023. Report No.: 12\/2023. Available from: https:\/\/www.julkari.fi\/bitstream\/handle\/10024\/147997\/URN_ISBN_978-952-408-217-4.pdf"},{"key":"1330_CR22","volume-title":"Beyond health Literacy - Youth Cultures, prevention and policy","author":"T Tammi","year":"2005","unstructured":"Tammi T. Diffusion of public health views on drug policy: the case of needle exchange in Finland. In: Hoikkala T, Hakkarainen P, Laine S, editors. Beyond health Literacy - Youth Cultures, prevention and policy. Helsinki: Finnish Youth Research Network; 2005."},{"key":"1330_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103130","volume":"95","author":"TM Brunt","year":"2021","unstructured":"Brunt TM, Lefran\u00e7ois E, Gunnar T, Arponen A, Seyler T, Goudriaan AE, et al. Substances detected in used syringes of injecting drug users across 7 cities in Europe in 2017 and 2018: the European syringe collection and analysis project enterprise (ESCAPE). Int J Drug Policy. 2021;95:103130.","journal-title":"Int J Drug Policy"},{"key":"1330_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.fsir.2025.100408","volume":"11","author":"P Kriikku","year":"2025","unstructured":"Kriikku P, Edvardsen HME, Thelander G, Thordardottir S, Andersen CU, Ojanper\u00e4 I, et al. Fatal poisonings in Nordic countries in 2022 among people who use drugs. Forensic Sci Int Rep. 2025;11:100408.","journal-title":"Forensic Sci Int Rep"},{"key":"1330_CR25","unstructured":"European Union Drugs Agency. European Drug Report 2024: Trends and Developments. 2024."},{"key":"1330_CR26","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1108\/DHS-12-2021-0063","volume":"23","author":"T Kaskela","year":"2022","unstructured":"Kaskela T, J\u00e4rvelin R, Nahkuri J, Gunnar T, Kankaanp\u00e4\u00e4 A, Pelander A, et al. Substance residue analysis as an alternative to drug checking? Traces from drug paraphernalia as a source for laboratory analysis. Drugs, Habits and Social Policy. 2022;23:277\u201388.","journal-title":"Drugs, Habits and Social Policy"},{"key":"1330_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-021-00585-2","volume":"19","author":"KM Scarfone","year":"2022","unstructured":"Scarfone KM, Maghsoudi N, McDonald K, Stefan C, Beriault DR, Wong E, et al. Diverse psychotropic substances detected in drug and drug administration equipment samples submitted to drug checking services in Toronto, Ontario, Canada, October 2019\u2013April 2020. Harm Reduct J. 2022;19:3.","journal-title":"Harm Reduct J"},{"key":"1330_CR28","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1021\/jasms.1c00232","volume":"32","author":"H West","year":"2021","unstructured":"West H, Fitzgerald J, Hopkins K, Li E, Clark N, Tzanetis S, et al. Early warning system for illicit drug use at large public events: trace residue analysis of discarded drug packaging samples. J Am Soc Mass Spectrom. 2021;32:2604\u201314.","journal-title":"J Am Soc Mass Spectrom"},{"key":"1330_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/dta.1818","volume":"8","author":"M Sundstr\u00f6m","year":"2016","unstructured":"Sundstr\u00f6m M, Pelander A, Simojoki K, Ojanper\u00e4 I. Patterns of drug abuse among drug users with regular and irregular attendance for treatment as detected by comprehensive UHPLC-HR-TOF-MS. Drug Test Anal. 2016;8:39\u201346.","journal-title":"Drug Test Anal"},{"key":"1330_CR30","volume-title":"IBM SPSS statistics for windows","author":"IBM Corp","year":"2023","unstructured":"IBM Corp. IBM SPSS statistics for windows. Armonk, NY: IBM Corp; 2023."},{"key":"1330_CR31","unstructured":"Lumivero. NVivo qualitative data analysis software, Version 14. 2023."},{"key":"1330_CR32","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1093\/jat\/bkab006","volume":"46","author":"D Di Candia","year":"2022","unstructured":"Di Candia D, Boracchi M, Muccino E, Gentile G, Zoja R. The lethal cutting: an unexpected cause of death\u2014a methomyl acute intoxication. J Anal Toxicol. 2022;46:e28-35.","journal-title":"J Anal Toxicol"},{"key":"1330_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108300","volume":"218","author":"S Tobias","year":"2021","unstructured":"Tobias S, Shapiro AM, Grant CJ, Patel P, Lysyshyn M, Ti L. Drug checking identifies counterfeit Alprazolam tablets. Drug Alcohol Depend. 2021;218:108300.","journal-title":"Drug Alcohol Depend"},{"key":"1330_CR34","unstructured":"Sis\u00e4-Suomen Poliisi. Erityisen vaarallista huumausainetta Tampereella [Particularly dangerous narcotic found in Tampere]. 2022. https:\/\/poliisi.fi\/-\/erityisen-vaarallista-huumausainetta-tampereella"},{"key":"1330_CR35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jchemneu.2017.06.001","volume":"83\u201384","author":"O Kudlacek","year":"2017","unstructured":"Kudlacek O, Hofmaier T, Luf A, Mayer FP, Stockner T, Nagy C, et al. Cocaine adulteration. J Chem Neuroanat. 2017;83\u201384:75\u201381.","journal-title":"J Chem Neuroanat"},{"key":"1330_CR36","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/dar.13370","volume":"41","author":"SA Borden","year":"2022","unstructured":"Borden SA, Saatchi A, Vandergrift GW, Palaty J, Lysyshyn M, Gill CG. A new quantitative drug checking technology for harm reduction: pilot study in Vancouver, Canada using paper spray mass spectrometry. Drug Alcohol Rev. 2022;41:410\u20138.","journal-title":"Drug Alcohol Rev"},{"key":"1330_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2024.112297","volume":"365","author":"P Kriikku","year":"2024","unstructured":"Kriikku P, Ojanper\u00e4 I. Findings of synthetic cathinones in post-mortem toxicology. Forensic Sci Int. 2024;365:112297.","journal-title":"Forensic Sci Int"},{"key":"1330_CR38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.drugpo.2019.06.018","volume":"71","author":"G Bardwell","year":"2019","unstructured":"Bardwell G, Boyd J, Tupper KW, Kerr T. We don\u2019t got that kind of time, man. We\u2019re trying to get high! Exploring potential use of drug checking technologies among structurally vulnerable people who use drugs. Int J Drug Policy. 2019;71:125\u201332.","journal-title":"Int J Drug Policy"},{"key":"1330_CR39","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.scitotenv.2013.11.095","volume":"487","author":"A Kankaanp\u00e4\u00e4","year":"2014","unstructured":"Kankaanp\u00e4\u00e4 A, Ariniemi K, Heinonen M, Kuoppasalmi K, Gunnar T. Use of illicit stimulant drugs in Finland: a wastewater study in ten major cities. Sci Total Environ. 2014;487:696\u2013702.","journal-title":"Sci Total Environ"},{"key":"1330_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-020-00373-4","volume":"17","author":"B Wallace","year":"2020","unstructured":"Wallace B, Van Roode T, Pagan F, Phillips P, Wagner H, Calder S, et al. What is needed for implementing drug checking services in the context of the overdose crisis? A qualitative study to explore perspectives of potential service users. Harm Reduct J. 2020;17:29.","journal-title":"Harm Reduct J"},{"key":"1330_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-024-01014-w","volume":"21","author":"L Moran","year":"2024","unstructured":"Moran L, Ondocsin J, Outram S, Ciccarone D, Werb D, Holm N, et al. How do we understand the value of drug checking as a component of harm reduction services? A qualitative exploration of client and provider perspectives. Harm Reduct J. 2024;21:92.","journal-title":"Harm Reduct J"},{"key":"1330_CR42","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.drugpo.2012.08.002","volume":"24","author":"M Edland-Gryt","year":"2013","unstructured":"Edland-Gryt M, Skatvedt AH. Thresholds in a low-threshold setting: an empirical study of barriers in a centre for people with drug problems and mental health disorders. Int J Drug Policy. 2013;24:257\u201364.","journal-title":"Int J Drug Policy"},{"key":"1330_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-022-00727-0","volume":"19","author":"B Wallace","year":"2022","unstructured":"Wallace B, Van Roode T, Burek P, Hore D, Pauly B. Everywhere and for everyone: proportionate universalism as a framework for equitable access to community drug checking. Harm Reduct J. 2022;19:143.","journal-title":"Harm Reduct J"},{"key":"1330_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-020-00365-4","volume":"17","author":"T Goodyear","year":"2020","unstructured":"Goodyear T, Mniszak C, Jenkins E, Fast D, Knight R. Am i gonna get in trouble for acknowledging my will to be safe? Identifying the experiences of young sexual minority men and substance use in the context of an opioid overdose crisis. Harm Reduct J. 2020;17:23.","journal-title":"Harm Reduct J"},{"key":"1330_CR45","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.drugalcdep.2018.06.020","volume":"190","author":"KW Tupper","year":"2018","unstructured":"Tupper KW, McCrae K, Garber I, Lysyshyn M, Wood E. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting. Drug Alcohol Depend. 2018;190:242\u20135.","journal-title":"Drug Alcohol Depend"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01330-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01330-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01330-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T10:06:15Z","timestamp":1761905175000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-025-01330-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1330"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01330-9","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"10 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol was reviewed and approved by the Ethical Committee of the A-Clinic Foundation. Research permits were obtained from three NGOs and the city of Helsinki, which run the services where the samples were collected. The data were collected using pseudonyms, and no individual could be identified from the collected descriptive data. The visitors were informed that the data were also collected for research purposes, and that additional written information about the study was available. The interviewed staff members were informed both orally and in writing of the use of the interview data, and their written consent was obtained before the interviews were conducted.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No identified individual data were used in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"178"}}